title: At least two!
mesh_terms: D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D000925:Anticoagulants / Q000009:adverse effects*; D000068258:Bevacizumab; D006801:Humans; D009025:Morpholines / Q000009:adverse effects*; D000069552:Rivaroxaban; D013876:Thiophenes / Q000009:adverse effects*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000925:Anticoagulants; D009025:Morpholines; D013876:Thiophenes; D000068258:Bevacizumab; D000069552:Rivaroxaban